85 related articles for article (PubMed ID: 21981571)
1. Risk factors for microbial contamination of peripheral blood stem cell products.
Donmez A; Aydemir S; Arik B; Tunger A; Cilli F; Orman M; Tombuloglu M
Transfusion; 2012 Apr; 52(4):777-81. PubMed ID: 21981571
[TBL] [Abstract][Full Text] [Related]
2. Microbial contamination of hematopoietic progenitor cell products.
Namdaroğlu S; Tekgündüz E; Bozdağ SC; Durgun G; Sarıca A; Demiriz IŞ; Koçubaba S; Iskender G; Kayıkçı O; Altuntaş F
Transfus Apher Sci; 2013 Jun; 48(3):403-6. PubMed ID: 23664302
[TBL] [Abstract][Full Text] [Related]
3. Autologous transplant: microbial contamination of hematopoietic stem cell products.
Almeida ID; Schmalfuss T; Röhsig LM; Goldani LZ
Braz J Infect Dis; 2012; 16(4):345-50. PubMed ID: 22846122
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae.
Klein MA; Kadidlo D; McCullough J; McKenna DH; Burns LJ
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1142-9. PubMed ID: 17085307
[TBL] [Abstract][Full Text] [Related]
5. Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.
Reich-Slotky R; Wu F; Della-Latta P; Savage DG; Schwartz J
Transfusion; 2008 Nov; 48(11):2409-13. PubMed ID: 18657076
[TBL] [Abstract][Full Text] [Related]
6. PBPC collection techniques: standard versus large volume leukapheresis (LVL) in donors and in patients.
Gasová Z; Marinov I; Vodvárková S; Böhmová M; Bhuyian-Ludvíková Z
Transfus Apher Sci; 2005 Apr; 32(2):167-76. PubMed ID: 15784451
[TBL] [Abstract][Full Text] [Related]
7. Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine.
Jacobs MR; Good CE; Fox RM; Roman KP; Lazarus HM
Transfusion; 2013 Nov; 53(11):2690-6. PubMed ID: 23461309
[TBL] [Abstract][Full Text] [Related]
8. Large-volume leukapheresis yields more viable CD34+ cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+ cells.
Abrahamsen JF; Stamnesfet S; Liseth K; Hervig T; Bruserud O
Transfusion; 2005 Feb; 45(2):248-53. PubMed ID: 15660835
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood stem cell collection in multiple myeloma: a retrospective analysis of 6 years leukapheresis activity in 109 patients treated at the Istituto Nazionale dei Tumori of Milan.
Coluccia P; Montefusco V; Tunesi S; Avella M; Bompadre A; Longoni P; Milanesi M; De Carli A; Ravagnani F
J Clin Apher; 2009; 24(4):134-40. PubMed ID: 19591198
[TBL] [Abstract][Full Text] [Related]
10. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
[TBL] [Abstract][Full Text] [Related]
11. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).
Cassens U; Momkvist PH; Zuehlsdorf M; Mohr M; Kienast J; Berdel WE; Sibrowski W
Bone Marrow Transplant; 2001 Jul; 28(1):13-20. PubMed ID: 11498739
[TBL] [Abstract][Full Text] [Related]
13. PBPC collections: Management, techniques and risks.
Gašová Z; Bhuiyan-Ludvíková Z; Böhmová M; Marinov I; Vacková B; Pohlreich D; Trněný M
Transfus Apher Sci; 2010 Oct; 43(2):237-43. PubMed ID: 20678961
[TBL] [Abstract][Full Text] [Related]
14. Microbial contamination of hematopoietic progenitor cell products: clinical outcome.
Patah PA; Parmar S; McMannis J; Sadeghi T; Karandish S; Rondon G; Tarrand J; Champlin R; de Lima M; Shpall EJ
Bone Marrow Transplant; 2007 Aug; 40(4):365-8. PubMed ID: 17572714
[TBL] [Abstract][Full Text] [Related]
15. Microbial contamination of harvested bone marrow and peripheral blood.
Prince HM; Page SR; Keating A; Saragosa RF; Vukovic NM; Imrie KR; Crump M; Stewart AK
Bone Marrow Transplant; 1995 Jan; 15(1):87-91. PubMed ID: 7742761
[TBL] [Abstract][Full Text] [Related]
16. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
[TBL] [Abstract][Full Text] [Related]
17. Microbial contamination of peripheral blood stem cell collections.
Attarian H; Bensinger WI; Buckner CD; McDonald DL; Rowley SD
Bone Marrow Transplant; 1996 May; 17(5):699-702. PubMed ID: 8733684
[TBL] [Abstract][Full Text] [Related]
18. Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products.
Padley DJ; Dietz AB; Gastineau DA
Transfusion; 2007 Apr; 47(4):636-43. PubMed ID: 17381622
[TBL] [Abstract][Full Text] [Related]
19. Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?
Dal MS; Tekgündüz E; Çakar MK; Kaya AH; Namdaroğu S; Batgi H; Bekdemir F; Uncu Ulu B; Yiğenoğlu TN; Kılınç A; İskender D; Uğur B; Koçubaba Ş; İskender G; Altuntaş F
Transfus Apher Sci; 2016 Aug; 55(1):125-8. PubMed ID: 27184293
[TBL] [Abstract][Full Text] [Related]
20. Microbial contamination of autologous peripheral blood stem cell products: incidence, clinical outcome, quality control and management strategies.
Cheah PL; Ong CW; Crispin P
Pathology; 2011 Jun; 43(4):340-5. PubMed ID: 21532522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
